The Effects of Barberry Juice Consumption in Patients With Type 2 Diabetes
1 other identifier
interventional
46
0 countries
N/A
Brief Summary
The aim of this study was to investigate the effect of barberry juice (BJ) as a natural antioxidant, on cardiovascular risk factors in patients with type 2 diabetes (T2DM). In a randomized clinical trial study, 46 T2DM patients, 30-70 years old recruited from "Diabetes Association of Iran-Babul ". Patients were randomly allocated to either the BJ group (n=23) who consumed 200 ml of BJ daily for eight weeks, or the control group (n=23) with no intervention. At the baseline and the end of 8-week intervention, blood pressure and biochemical markers were conducted.
Trial Health
Trial Health Score
Automated assessment based on enrollment pace, timeline, and geographic reach
participants targeted
Target at P25-P50 for phase_4 type-2-diabetes
Started Dec 2016
Shorter than P25 for phase_4 type-2-diabetes
Health score is calculated from publicly available data and should be used for screening purposes only.
Trial Relationships
Click on a node to explore related trials.
Study Timeline
Key milestones and dates
Study Start
First participant enrolled
December 21, 2016
CompletedPrimary Completion
Last participant's last visit for primary outcome
April 16, 2017
CompletedStudy Completion
Last participant's last visit for all outcomes
August 5, 2017
CompletedFirst Submitted
Initial submission to the registry
September 27, 2017
CompletedFirst Posted
Study publicly available on registry
October 2, 2017
CompletedOctober 2, 2017
September 1, 2017
4 months
September 27, 2017
September 29, 2017
Conditions
Outcome Measures
Primary Outcomes (2)
fasting blood glucose
8 weeks
total cholesterol
8 weeks
Secondary Outcomes (6)
LDL- cholesterol
8 weeks
HDL- cholesterol
8 weeks
Triglyceride
8 weeks
HbA1c
8 weeks
Systolic BP
8 weeks
- +1 more secondary outcomes
Study Arms (2)
Intervention group
EXPERIMENTALpatients in this group were received 200 ml/d barberry juice for tow month
control group
NO INTERVENTIONpatients in this group received no intervention
Interventions
Eligibility Criteria
You may qualify if:
- Fasting blood glucose\>100 mg/dL (5.6 mmol /L)
- Systolic blood pressure\>130 mmHg or diastolic blood pressure\>85mmHg
- Triglycerides\> 150 mg/dL (1.7 mmol/L)
You may not qualify if:
- taking insulin
- smoking
- using antioxidant supplements
Contact the study team to confirm eligibility.
Sponsors & Collaborators
MeSH Terms
Conditions
Condition Hierarchy (Ancestors)
Study Design
- Study Type
- interventional
- Phase
- phase 4
- Allocation
- RANDOMIZED
- Masking
- NONE
- Purpose
- SUPPORTIVE CARE
- Intervention Model
- PARALLEL
- Sponsor Type
- OTHER
- Responsible Party
- PRINCIPAL INVESTIGATOR
- PI Title
- National Nutrition and Food Technology Research Institute
Study Record Dates
First Submitted
September 27, 2017
First Posted
October 2, 2017
Study Start
December 21, 2016
Primary Completion
April 16, 2017
Study Completion
August 5, 2017
Last Updated
October 2, 2017
Record last verified: 2017-09